We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finds Postmarket Trials for Drugs and Biologics on Track
FDA Finds Postmarket Trials for Drugs and Biologics on Track
Drug and biologic sponsors are generally complying with requirements or agreed commitments for postmarketing clinical trials, according to the latest report from the FDA.